|
Stephen R. Lee, Ph.D. joined the Company September 2005, as Executive Vice President and Chief Science Officer.
Dr. Lee brings twenty years of experience in the immunodiagnostic industry primarily with Ortho Clinical Diagnostics, a Johnson & Johnson company. While at Ortho, Dr. Lee served as Vice President, Assay Research & Development, Executive Director, Worldwide Immunodiagnostic Product Development and Director, Infectious Disease Assay Development. Dr. Lee has had responsibility for or direct involvement in the development of over 40 major diagnostic assays, in such areas as infectious disease, cardiology, oncology and other conditions. In 1997, Dr. Lee was awarded The Johnson Medal, Johnson & Johnson’s highest award for Research and Development. Prior to joining Ortho, Dr. Lee worked as a scientist for both Wampole Labs and Immunicon Corporation.
Dr. Lee received his Ph.D. degree in BioChemistry from Cardiff University (U.K.) and his BSc. in Biochemistry from Sheffield University (U.K.). | 